SUMMARY The serum concentrations of serum amyloid-A protein (SAA), C-reactive protein (CRP), and alpha,-acid glycoprotein (alpha,-AGP) have been measured in 185 patients with rheumatoid arthritis. SAA and CRP concentrations correlated well (r=086) both within and above the normal ranges, though SAA showed a greater incremental increase than CRP. All patients with normal SAA levels also had normal CRP and alpha1-AGP concentrations. In contrast, in 40 % of patients with normal CRP and alpha1-AGP concentrations the SAA was raised, sometimes markedly so. The clinical and serological assessments of disease activity in these patients were not significantly different from those with concomitantly raised levels of CRP. These findings suggest that SAA is a more sensitive marker of inflammation than is CRP. The role of the measurement of SAA as a monitor for inflammatory disease activity is discussed.
Measurements of the serum acute-phase proteins are of value in the assessment of the activity and prognosis and also in the monitoring of response to treatment in chronic inflammatory diseases such as rheumatoid arthritis.1-3 C-reactive protein (CRP) has been most widely used in this context. 4 More recently a new acute-phase protein, serum amyloid-A (SAA) protein, has been described.56 SAA is a normal alpha1 globulin which is thought to be the circulating precursor of tissue amyloid-AA. Increased concentrations of SAA have been reported in a number of inflammatory diseases,7 8 including rheumatoid arthritis (RA) and juvenile rheumatoid arthritis. 9 10 Despite the fact that the evidence suggests a single macrophage-derived messenger (interleukin I) as being responsible for switching on acute-phase protein synthesis in the liver,11 not all acute-phase proteins are raised in parallel in many diseases.12 These discrepancies may result from differential consumption of proteins in the inflammatory process or a selective response on the part of the liver. Whatever the explanation, the phenomenon suggests that certain of the acute-phase proteins may be of particular Accepted for publication 11 
Patients and methods
Inpatients and outpatients were included in the study. Data on age, sex, duration of rheumatoid arthritis, presence of systemic features, and drug therapy were recorded. Disease activity was assessed clinically and by haemoglobin and plasma viscosity measurement. X-rays were examined for the presence of erosions, and rheumatoid factor was estimated. The patients could thus be broadly categorised as having early active, active erosive, and inactive or long-standing destructive disease.
Serum was separated from clotted venous blood and stored at -20°C. SAA levels were measured by a modified radial immunodiffusion method described elsewhere.14 CRP was measured by simple radial immunodiffusion"5 and alpha1-AGP by the Laurell 
Results
A total of 185 patients with rheumatoid arthritis were studied over a period of one year. In some cases acute-phase proteins were measured on more than one occasion, resulting in 305 sets of measurements.
A comparison of serum SAA and CRP concentrations is shown in Fig. 1 . There is a correlation of the results (r=0-86) over a wide range of concentrations, both within and above the normal ranges. SAA, however, shows a greater incremental change in rheumatoid arthritis than CRP, the maximum observed concentration being in the range of 3 to 4 g/l as compared with CRP levels of 200 to 250 mg/l.
More interestingly it can be seen that increased SAA levels are present in the face of normal CRP concentrations. This is clearly illustrated in Fig. 2 
